JUDIT PALLARES QUIXAL-rekin lankidetzan egindako argitalpenak (13)

2024

  1. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum

    Frontiers in Endocrinology, Vol. 15

2011

  1. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

    American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543

  2. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma

    Human Pathology, Vol. 42, Núm. 2, pp. 185-193

2010

  1. The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms

    European Journal of Cancer, Vol. 46, Núm. 4, pp. 836-850

2009

  1. A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma

    Analytical and Quantitative Cytology and Histology, Vol. 31, Núm. 4, pp. 217-226

  2. CK2β is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation

    American Journal of Pathology, Vol. 174, Núm. 1, pp. 287-296

  3. Molecular pathology of endometrial carcinoma: Practical aspects from the diagnostic and therapeutic viewpoints

    Journal of Clinical Pathology, Vol. 62, Núm. 9, pp. 777-785

2008

  1. CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells

    Oncogene, Vol. 27, Núm. 18, pp. 2513-2524

  2. Loss of heterozygosity in endometrial carcinoma

    International Journal of Gynecological Pathology, Vol. 27, Núm. 3, pp. 305-317

  3. Nuclear factor-κB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma

    Human Pathology, Vol. 39, Núm. 7, pp. 994-1001

  4. Targeted therapies in gynecologic cancers and melanoma

    Seminars in Diagnostic Pathology, Vol. 25, Núm. 4, pp. 262-273

2006

  1. PIK3CA gene mutations in endometrial carcinoma. Correlation with PTEN and K-RAS alterations

    Human Pathology, Vol. 37, Núm. 11, pp. 1465-1472

  2. Proteasome inhibitors induce death but activate NF-κB on endometrial carcinoma cell lines and primary culture explants

    Journal of Biological Chemistry, Vol. 281, Núm. 31, pp. 22118-22130